Issue |
J Extra Corpor Technol
Volume 56, Number 2, June 2024
|
|
---|---|---|
Page(s) | 77 - 81 | |
DOI | https://doi.org/10.1051/ject/2024005 | |
Published online | 18 June 2024 |
Technique or Application
Venovenous bypass in liver transplantation: Exploring the benefits, efficacy, and safety
1
Perfusionist & ECMO Specialist, Heart Vascular and Thoracic Institute, Cleveland Clinic, PO Box: 112412, Abu Dhabi, United Arab Emirates
2
Department Chair, Cardiothoracic Aesthesia, Anesthesiology Institute, Cleveland Clinic, Abu Dhabi, United Arab Emirates
3
Anesthesiology Physician, Anesthesiology Institute, Cleveland Clinic, Abu Dhabi, United Arab Emirates
4
Anesthesiology Institute, Cleveland Clinic, Abu Dhabi, United Arab Emirates
5
Digestive Disease Institute, Cleveland Clinic, Abu Dhabi, United Arab Emirates
6
Institute Chair, Digestive Disease Institute, Cleveland Clinic, Abu Dhabi, United Arab Emirates
* Corresponding author: buttsab9@hotmail.com
Received:
26
October
2023
Accepted:
4
March
2024
Venovenous bypass (VVB) is a technique used in liver transplantation (LT) to maintain hemodynamic stability and abdominal organ perfusion and thereby improve patient outcomes. Despite its perceived benefits, VVB utilization has declined globally due to concerns related to heparinization, major bleeding and the need for expertise. Recent advancements, such as percutaneous cannulation techniques and improved extracorporeal technology have improved the safety of VVB in LT. This paper presents a modified VVB circuit with enhanced safety features. Cannulation plays a pivotal role in VVB establishment, with percutaneous methods increasingly favored. Studies demonstrate VVB’s efficacy in improving patient outcomes with lower incidence of acute kidney injury and reduced operative time and blood loss, with no added morbidity or mortality. However, its routine use faces challenges, with alternative techniques gaining traction. Our experience highlights VVB’s role in various clinical scenarios, including patients with high Model for End-Stage Liver Disease (MELD) scores, challenging surgical anatomy, portal vein thrombosis and pre-existing cardiovascular disease, emphasizing its safety and efficacy. Continued research is needed to optimize VVB techniques and ensure better outcomes for liver transplant recipients.
Key words: Liver transplant / Venovenous bypass / Benefits
© The Author(s), published by EDP Sciences, 2024
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.